journals.iucr.org
Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening
In this first instance of crystallographic fragment screening completed by the crystallographic fragment-screening platform of the Shanghai Synchrotron Radiation Facility (SSRF) in China, 800 fragments were screened and 91 compounds were identified to bind at eight different sites.